In the current compilation of Warning Letters issued between 2009 and 2011 we have summarised for you the key points regarding the use of high performance liquid chromatography (HPLC).

The inspection focuses can be summarised and compiled in the following 4 themes:

• Raw Data / Protection of Electronic Records
• Calibration / Qualification
• Method Validation
• System Suitability / Sequences

Go here to access the complete list of FDA findings regarding HPLC.

All these topics and further important aspects of a GMP/FDA compliant use of HPLC in the GMP laboratory will be covered in detail and discussed in ECA's Education Course "Maximising HPLC Productivity" from 18 - 20 April 2012 in Prague. This event will be a great opportunity for you to prepare your HPLC lab for the next FDA inspection.

Author:
Dr Günter Brendelberger
CONCEPT HEIDELBERG (a service provider entrusted by the ECA Foundation)

Related GMP News
22/05/2013	Handling of APIs and Excipients - New Guidelines in Chapter 5 of EU GMP Guide
29/04/2013	New USP Chapter on Inhalation Drug Products
24/04/2013	Revision of the EU GMP Guide: EU Commission Proposal for Chapter 6 - Quality Control
17/04/2013	Quality Standards on Recovered Solvents in the Manufacture of Herbal Medicinal Products
13/02/2013	Laboratory Data Integrity in FDA Warning Letters 2012